Medical Cannabis

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.

United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.

The proceeds raised from the special Veterans Day webcast will help support the families of America's fallen military heroes.

Welcome to the first edition of Cannabis Patient Care!

A report on the findings from the anonymous 2019 Veterans Health and Medical Cannabis Study, which was a national and Massachusetts-focused research study led by Dr. Marion McNabb, Stephen Mandile, and Dr. Stephen White.

Stephen Mandile—veteran, cannabis patient, and advocate—shares his personal experience with medical cannabis and how it has given him a new mission to help other veterans gain access to this plant.

An in-depth conversation with Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core, Director of Marijuana Investigations for Neuroscientific Discovery (MIND) at McLean Hospital, and Associate Professor of Psychiatry at Harvard Medical School on her interest in medical cannabis and the medical cannabis research areas that MIND is focusing on for veterans and beyond.

Ann M. Brum and Wayne Smith discuss their roles as cannabis advocates fighting for reform and veteran access to medical cannabis.

Tracey Gregory, RN, discusses her experiences with veteran patients with PTSD, her work with Hospice for Heroes, medical cannabis, and more.

Jamie Pascua, a Veterans Affairs caregiver, shares her unique perspective on medical cannabis and her role caring for her disabled veteran spouse.

Dr. Junella Chin, the Founder of MedLeaf RX and the Chief Medical Advisor for Yesterday Wellness, discusses with us the beneficial aspects CBD and how the medical field is beginning to incorporate the concept of medical cannabis into patient treatments.

A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.

Tilray, Inc. announced that one of their GMP products is showing a potential benefit in reducing nausea and vomiting caused by chemotherapy.

An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.

An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.

A tribute piece to Charlotte Figi, a medical cannabis and CBD pioneer who inspired the name of the medical cannabis strain Charlotte’s Web.

Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.

Commentary on how medicinal cannabis can evolve in a similar manner as the pharmaceutical industry did.

A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.

Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.

A review of the literature to examine the analgesic properties of cannabis.

What changes need to be adopted in our industry to make the transition to the pharmaceutical industry testing paradigm?

GW Pharmaceuticals recently announced the company’s financial results from the second quarter of 2019.

Big Pharma is working on locking up cannabis patents, creating partnerships, and standing by to use its financial muscle for more ownership of the medical cannabis industry when the time is right.

Lesser known cannabinoids and terpenes may be helpful for patients. Here the author shows why, and how patients can choose more effective medical cannabis products.

By understanding whole-plant extractions better, businesses will be able to better plan for long-term profitability and sustainability.  

David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.

In honor of National Women’s Month, Josh Crossney highlights some of the amazing women that will be speaking at the first Cannabis Science Conference East show.